These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1406908

  • 1. Assessment of buprenorphine in a drug discrimination procedure in humans.
    Bigelow GE, Preston KL.
    NIDA Res Monogr; 1992; 121():28-37. PubMed ID: 1406908
    [Abstract] [Full Text] [Related]

  • 2. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE, Bigelow GE, Preston KL.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [Abstract] [Full Text] [Related]

  • 3. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [Abstract] [Full Text] [Related]

  • 4. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL, Bigelow GE, Bickel WK, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [Abstract] [Full Text] [Related]

  • 5. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination.
    Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):62-71. PubMed ID: 1373189
    [Abstract] [Full Text] [Related]

  • 6. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
    [Abstract] [Full Text] [Related]

  • 7. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
    Strain EC, Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):985-93. PubMed ID: 1376362
    [Abstract] [Full Text] [Related]

  • 8. Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
    Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):47-53. PubMed ID: 2459370
    [Abstract] [Full Text] [Related]

  • 9. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [Abstract] [Full Text] [Related]

  • 10. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA, Holtzman SG.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [Abstract] [Full Text] [Related]

  • 11. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
    Preston KL, Bigelow GE, Bickel W, Liebson IA.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
    [Abstract] [Full Text] [Related]

  • 12. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC, Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [Abstract] [Full Text] [Related]

  • 13. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
    Strain EC, Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
    [Abstract] [Full Text] [Related]

  • 14. Acute administration of buprenorphine in humans: partial agonist and blockade effects.
    Walsh SL, Preston KL, Bigelow GE, Stitzer ML.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):361-72. PubMed ID: 7542336
    [Abstract] [Full Text] [Related]

  • 15. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG.
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the discriminative stimulus effects of buprenorphine in pigeons.
    Galici R, Brandt MR, France CP.
    Psychopharmacology (Berl); 2002 Mar; 160(2):132-9. PubMed ID: 11875630
    [Abstract] [Full Text] [Related]

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Mar; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 18. Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect.
    Bickel WK, Bigelow GE, Preston KL, Liebson IA.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1053-63. PubMed ID: 2481029
    [Abstract] [Full Text] [Related]

  • 19. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ, Cook CD.
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.